Brian J Lee1, Ken Forbes. 1. Kaiser Permanente, Hawaii Region, Moanalua Medical Center, 3288 Moanalua Rd, Honolulu, HI 96819, USA. brian.j.lee@kp.org
Abstract
PROBLEM: Specialty care has been used to manage individual patients at the discretion of generalists but not to drive improvements at the population level. DESIGN: Observational longitudinal study. SETTING: Kaiser Permanente Hawaii, with more than 10,000 members with documented chronic kidney disease. KEY MEASURES FOR IMPROVEMENT: Rate of late referrals to nephrology care, defined as occurring within four months of end stage renal disease and the proportions of patients starting haemodialysis with a mature arteriovenous fistula and starting dialysis in the outpatient setting. STRATEGIES FOR CHANGE: Risk stratification of the entire population and unsolicited consultations provided by nephrologists to generalists, based on patients' risk level, enabled by an electronic population management database. EFFECTS OF CHANGE: Between 2004 and 2008, the proportion of referrals occurring within four months of onset of end stage renal disease dropped from 37 of 116 (32%) to 10 of 84 (12%), P=0.001. The proportion of patients starting haemodialysis with a mature arteriovenous fistula increased from 19 of 108 (18%) to 27 of 76 (36%), P=0.006. The proportion of patients who started haemodialysis as outpatients increased from 39 of 113 (35%) to 47 of 84 (56%), P=0.003. LESSONS LEARNT: Turning the traditional referral system on its head by providing unsolicited, risk driven nephrology consultations is an effective strategy for increasing the quality of medical management of patients with chronic kidney disease in the primary care setting and improving the cost effective use of nephrology services. This approach may be broadly applicable to other specialty areas.
PROBLEM: Specialty care has been used to manage individual patients at the discretion of generalists but not to drive improvements at the population level. DESIGN: Observational longitudinal study. SETTING: Kaiser Permanente Hawaii, with more than 10,000 members with documented chronic kidney disease. KEY MEASURES FOR IMPROVEMENT: Rate of late referrals to nephrology care, defined as occurring within four months of end stage renal disease and the proportions of patients starting haemodialysis with a mature arteriovenous fistula and starting dialysis in the outpatient setting. STRATEGIES FOR CHANGE: Risk stratification of the entire population and unsolicited consultations provided by nephrologists to generalists, based on patients' risk level, enabled by an electronic population management database. EFFECTS OF CHANGE: Between 2004 and 2008, the proportion of referrals occurring within four months of onset of end stage renal disease dropped from 37 of 116 (32%) to 10 of 84 (12%), P=0.001. The proportion of patients starting haemodialysis with a mature arteriovenous fistula increased from 19 of 108 (18%) to 27 of 76 (36%), P=0.006. The proportion of patients who started haemodialysis as outpatients increased from 39 of 113 (35%) to 47 of 84 (56%), P=0.003. LESSONS LEARNT: Turning the traditional referral system on its head by providing unsolicited, risk driven nephrology consultations is an effective strategy for increasing the quality of medical management of patients with chronic kidney disease in the primary care setting and improving the cost effective use of nephrology services. This approach may be broadly applicable to other specialty areas.
Authors: Ron T Gansevoort; Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh Journal: Kidney Int Date: 2011-02-02 Impact factor: 10.612
Authors: Paul E Drawz; Patrick Archdeacon; Clement J McDonald; Neil R Powe; Kimberly A Smith; Jenna Norton; Desmond E Williams; Uptal D Patel; Andrew Narva Journal: Clin J Am Soc Nephrol Date: 2015-06-25 Impact factor: 8.237
Authors: Stacey E Jolly; Sankar D Navaneethan; Jesse D Schold; Susana Arrigain; John W Sharp; Anil K Jain; Martin J Schreiber; James F Simon; Joseph V Nally Journal: Am J Nephrol Date: 2014-04-01 Impact factor: 3.754
Authors: Nynke D Scherpbier-de Haan; Vincent A van Gelder; Chris Van Weel; Gerald M M Vervoort; Jack F M Wetzels; Wim J C de Grauw Journal: Ann Fam Med Date: 2013 Mar-Apr Impact factor: 5.166
Authors: Stein I Hallan; Kunihiro Matsushita; Yingying Sang; Bakhtawar K Mahmoodi; Corri Black; Areef Ishani; Nanne Kleefstra; David Naimark; Paul Roderick; Marcello Tonelli; Jack F M Wetzels; Brad C Astor; Ron T Gansevoort; Adeera Levin; Chi-Pang Wen; Josef Coresh Journal: JAMA Date: 2012-12-12 Impact factor: 56.272
Authors: Kunihiro Matsushita; Bakhtawar K Mahmoodi; Mark Woodward; Jonathan R Emberson; Tazeen H Jafar; Sun Ha Jee; Kevan R Polkinghorne; Anoop Shankar; David H Smith; Marcello Tonelli; David G Warnock; Chi-Pang Wen; Josef Coresh; Ron T Gansevoort; Brenda R Hemmelgarn; Andrew S Levey Journal: JAMA Date: 2012-05-09 Impact factor: 56.272